FIELD: medicine.
SUBSTANCE: medicinal product containing an activated potentiated form of antibodies to an antigen involved into a disease process, is administered in a combination with an activated potentiated form of antibodies to endothelial NO-synthase.
EFFECT: higher therapeutic effectiveness of the medicinal product ensured by the intensifying effect of the activated potentiated antibodies to endothelial NO-synthase.
10 cl, 26 tbl, 16 ex
Authors
Dates
2016-01-20—Published
2014-06-30—Filed